Skip to main content

Select Drug Profiles

Payers' Guide
Imlygic (Talimogene Laherparepvec): First Oncolytic Viral Therapy for the Treatment of Patients with Recurrent Melanoma
Lisa A. Raedler, PhD, RPh
Read More
Payers' Guide
Finacia Foam (Azelaic Acid) the Newest Topical Treatment FDA Approved for the Treatment of Inflammatory Lesions of Rosacea
Loretta Fala
Read More
Payers' Guide
Ibrance (Palbociclib): First CDK4 and CDK6 Inhibitor Approved for Postmenopausal Women with Metastatic Breast Cancer
Lisa A. Raedler, PhD, RPh
Read More
Perspectives
Convergence in Healthcare: Providers, Employers, and Health Plans
Byron C. Scott, MD, MBA
Read More
Original Research
Patient Characteristics and Prescribing Patterns Associated with Sofosbuvir Treatment for Chronic HCV Infection in a Commercially Insured Population
Brent M. Tambourine, PharmD, BCPS, Arash Sadeghi, PharmD, Jianing Yang, MD, MS, Karen M. Stockl, PharmD, Heidi C. Lew, PharmD, Brian K. Solow, MD, FAAFP, Josephine N. Tran, PharmD, MS
Stakeholder Perspective
Taking Steps to Cure Chronic Hepatitis C Virus Infection
by Atheer A. Kaddis, PharmD
Read More
Original Research
Patient Preferences Regarding Rheumatoid Arthritis Therapies: A Conjoint Analysis
Anthony M. Louder, PhD, RPh, Amitabh Singh, PhD, Kim Saverno, PhD, Joseph C. Cappelleri, PhD, Aaron J. Aten, PharmD, BCPS, Andrew S. Koenig, DO, FACR, Margaret K. Pasquale, PhD
Stakeholder Perspective
Challenges in the Assessment of Patient Preferences among RA Therapies
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Practice Management
Inpatient Utilization and Costs for Medicare Fee-for-Service Beneficiaries with Heart Failure
Kathryn Fitch, RN, MEd, Pamela M. Pelizzari, MPH, Bruce S. Pyenson, FSA, MAAA
Stakeholder Perspective
Validating the Impact of Heart Failure Through the Law of Large Numbers
by Albert Tzeel, MD, MHSA, CPE, FAAPL
Read More
FDA Approvals, In the News
Venclexta FDA Approved for Patients with CLL
Read More
Letters to the Editor, In the News
Correspondence: Developing a Model Framework to Assess Cost of Therapy
Read More
FDA Approvals, In the News
FDA Approves Infliximab Biosimilar for Multiple Indications
Read More
Page 113 of 244
Results 1121 - 1130 of 2434